tirzepatide in mash 🔴 #SYNERGY_NASH Trial (NEJM, 2024) for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis 👉 this phase 2 trial involving participants with and moderate or severe fibrosis, treatment with tirzepatide for Study show tirzepatide beneficial for

In those women achieving a high dose of semaglutide, there were no differences in any of the baseline demographic, social, and anthropometric characteristics among HT and no-HT use (Supplemental Table 1, Among the entire cohort, 14% were using weight-promoting medications at the same time of semaglutide use

Although AOD 9604 does not affect blood sugar, people actively managing diabetes with medication should monitor more carefully when adding any new compound to their regimen

Most patients experience mild symptoms like nausea or diarrhea

Combination Therapy with Metformin : In a 56-week trial , OZEMPIC combined with metformin resulted in a significant HbA1c reduction of 1.5% (for 1 mg dose) compared to sitagliptin